drugset
Drugs / Fecal Microbiota Enema
last change Dec 2018 re-read 3 minutes ago

Fecal Microbiota Enema

also known as RBX-2660
Developed for
ulcerative colitis
Investigated by
London Health Sciences Centre · McMaster Children's Hospital · St. Justine's Hospital

Trials 1

today NCT02487238 · Ph 1
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02487238 Nov 2015 → Dec 2018 ulcerative colitis McMaster Children's Hospital Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fecal Microbiota Enema ClinicalTrials.gov intervention name — accepted as the source's own label NCT02487238 ↗
Known as RBX-2660 “Fecal enemas will contain healthy donor stool that has been extensively safety-screened and provided by Rebiotix® (RBX-2660).” NCT02487238 ↗
Route Rectal “twice-weekly retention enemas delivered over six weeks” NCT02487238 ↗